Ocular Therapeutix is dedicated to becoming the lead developer of sustained ophthalmic therapies with proprietary tailored hydrogels to improve patient experience and outcomes.
ReSure® Sealant is indicated for intraoperative management of clear corneal incisions (up to 3.5mm) with a demonstrated wound leak for which a temporary dry surface can be achieved, in order to prevent postoperative fluid egress from such incisions following cataract surgery with intraocular lens (IOL) placement in adults.
Caution: New Drug – Sustained release intracanalicular depots are investigational new drugs and not commercially available in the United States.
Sustained Protein Delivery
Evaluating sustained-release injectable drug depots for back-of-the-eye diseases.
Caution: New Drug – Sustained release protein is an investigational new drug and not commercially available in the United States.